Animal models of autism

Drug Discovery Today: Disease Models

Volumn 3, Issue 4, 2006, Pages 313-318

  Klauck, Sabine M ^a   Poustka, Annemarie ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLIGIN; SEROTONIN RECEPTOR; SEROTONIN TRANSPORTER;

ANIMAL BEHAVIOR; AUTISM; DEVELOPMENTAL DISORDER; DISEASE MODEL; EXPERIMENTAL ANIMAL; EXPERIMENTAL MOUSE; GENETIC MODEL; GENETIC SUSCEPTIBILITY; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; MOUSE STRAIN; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PHENOTYPE; REVIEW; SYMPTOM; TRANSGENIC ANIMAL;

EID: 33846615458     PISSN: 17406757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddmod.2006.11.005     Document Type: Review

References (46)

1. American Psychiatric Association, (1994) Diagnostic and Statistical Manual of Mental Disorders (4th edn), Washington DC, USA
2. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 33 (2003) 365-382
3. Pickles A., et al. Latent-class analysis of recurrence risks for complex phenotypes with selection and measurement error: a twin and family history study of autism. Am. J. Hum. Genet. 57 (1995) 717-726
4. Pritchard J.K. Are rare variants responsible for susceptibility to complex diseases?. Am. J. Hum. Genet. 69 (2001) 124-137
5. Palmen S.J., et al. Neuropathological findings in autism. Brain 127 (2004) 2572-2583
6. Crawley J.N. Designing mouse behavioral tasks relevant to autistic-like behaviors. Ment. Retard. Dev. Disabil. Res. Rev. 10 (2004) 248-258
7. Moy S.S., et al. Mouse models of autism spectrum disorders: the challenge for behavioral genetics. Am. J. Med. Genet. C Semin. Med. Genet. 142C (2006) 40-51
8. Moy S.S., et al. Sociability and preference for social novelty in five inbred strains: an approach to assess autistic-like behavior in mice. Genes Brain Behav. 3 (2004) 287-302
9. Sankoorikal G.M., et al. A mouse model system for genetic analysis of sociability: C57BL/6J versus BALB/cJ inbred mouse strains. Biol. Psychiatry 59 (2006) 415-423
10. Andres C. Molecular genetics and animal models in autistic disorder. Brain Res. Bull. 57 (2002) 109-119
11. Belzung C., et al. Rodent models for autism: a critical review. Drug Discov. Today Dis. Models 2 (2005) 93-101
12. Franke U. Mechanisms of disease: neurogenetics of MeCP2 deficiency. Nat. Clin. Pract. Neurol. 2 (2006) 212-221
13. Moretti P., et al. Abnormalities of social interaction and home-cage behavior in a mouse model of Rett syndrome. Hum. Mol. Genet. 14 (2005) 205-220
14. Asaka Y., et al. Hippocampal synaptic plasticity is impaired in the Mecp2-null mouse model of Rett syndrome. Neurobiol. Dis. 21 (2006) 217-227
15. DiCicco-Bloom E., et al. The developmental neurobiology of autism spectrum disorder. J. Neurosci. 26 (2006) 6897-6906
16. Young L.J., and Wang Z. The neurobiology of pair bonding. Nat. Neurosci. 7 (2004) 1048-1054
17. Tropepe V., and Sive H.L. Can zebrafish be used as a model to study the neurodevelopmental causes of autism?. Genes Brain Behav. 2 (2003) 268-281
18. McBride S.M., et al. Pharmacological rescue of synaptic plasticity, courtship behavior, and mushroom body defects in a Drosophila model of fragile X syndrome. Neuron 45 (2005) 753-764
19. Hemby S.E., et al. Functional genomics approaches to a primate model of autistic symptomatology. J. Autism Dev. Disord. 31 (2001) 551-555
20. Murcia C.L., et al. A question of balance: a proposal for new mouse models of autism. Int. J. Dev. Neurosci. 23 (2005) 265-275
21. Bachevalier J. Brief report: medial temporal lobe and autism: a putative animal model in primates. J. Autism Dev. Disord. 26 (1996) 217-220
22. Wolterink G., et al. Early amygdala damage in the rat as a model for neurodevelopmental psychopathological disorders. Eur. Neuropsychopharmacol. 11 (2001) 51-59
23. Narita N., et al. Increased monoamine concentration in the brain and blood of fetal thalidomide- and valproic acid-exposed rat: putative animal models for autism. Pediatr. Res. 52 (2002) 576-579
24. Anderson G.M., et al. The hyperserotonemia of autism. Ann. N.Y. Acad. Sci. 600 (1990) 331-340
25. Schneider T., and Przewłocki R. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 (2005) 80-89
26. Lancaster K., et al. Abnormal social behaviors in young and adult rats neonatally infected with Borna disease virus. Behav. Brain Res. 176 (2007) 141-148
27. Sadamatsu M., et al. Review of animal models for autism: implication of thyroid hormone. Congenit. Anom. (Kyoto) 46 (2006) 1-9
28. Gaspar P., et al. The developmental role of serotonin: news from mouse molecular genetics. Nat. Rev. Neurosci. 4 (2003) 1002-1012
29. Gingrich J.A., et al. New lessons from knockout mice: the role of serotonin during development and its possible contribution to the origins of neuropsychiatric disorders. CNS Spectr. 8 (2003) 572-577
30. Lim M.M., et al. Neuropeptides and the social brain: potential rodent models of autism. Int. J. Dev. Neurosci. 23 (2005) 235-243
31. D'Arcangelo G. The reeler mouse: anatomy of a mutant. Int. Rev. Neurobiol. 71 (2005) 383-417
32. Fatemi S.H. Reelin mutations in mouse and man: from reeler mouse to schizophrenia, mood disorders, autism and lissencephaly. Mol. Psychiatry 6 (2001) 129-133
33. Lijam N., et al. Social interaction and sensorimotor gating abnormalities in mice lacking. Dvl1. Cell 90 (1997) 895-905
34. Rosso S.B., et al. Wnt signaling through Dishevelled, Rac and JNK regulates dendritic development. Nat. Neurosci. 8 (2005) 34-42
35. Kwon C.-H., et al. Pten regulates neuronal arborization and social interaction in mice. Neuron 50 (2006) 377-388
36. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 34 (2003) 27-29
37. Varoqueaux F., et al. Neuroligins determine synapse maturation and function. Neuron 51 (2006) 741-754
38. Peng S., et al. A transgenic approach for RNA interference-based genetic screening in mice. Proc. Natl. Acad. Sci. U S A 103 (2006) 2252-2256
39. Thakker D.R., et al. siRNA-mediated knockdown of the serotonin transporter in the adult mouse brain. Mol. Psychiatry 10 (2005) 782-789
40. Chih B., et al. Disorder-associated mutations lead to functional inactivation of neuroligins. Hum. Mol. Genet. 13 (2004) 1471-1477
41. Comoletti D., et al. The Arg451Cys-neuroligin-3 mutation associated with autism reveals a defect in protein processing. J. Neurosci. 24 (2004) 4889-4893
42. Klauck S.M., et al. Mutations in the ribosomal protein gene RPL10 suggest a novel modulating disease mechanism for autism. Mol. Psychiatry 11 (2006) 1073-1074
43. Klauck S.M. Genetics of autism spectrum disorder. Eur. J. Hum. Genet. 14 (2006) 714-720
44. Feng J., et al. High frequency of neurexin 1ß signal peptide structural variants in patients with autism. Neurosci. Lett. 409 (2006) 10-13
45. Persico A.M., et al. Searching for ways out of the autism maze: genetic, epigenetic and environmental clues. Trends Neurosci. 29 (2006) 349-358
46. Campbell D.B., et al. A genetic variant that disrupts MET transcription is associated with autism. Proc. Natl. Acad. Sci. U S A 103 (2006) 16834-16839